HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of Ia antigens in a murine T-lymphoma variant.

Abstract
ESb, a cellular high metastatic variant derived from the murine T-cell lymphoma L5178Y (Eb), was found to synthesize Ia antigens. Ia-specific antibodies reacted with the ESb cells and precipitated Ia-like molecules from them. Two-dimensional gel electrophoretic analysis of immunoprecipitates of metabolically labeled ESb cells indicated that the Ia molecules on ESb were indistinguishable from those on murine B-cells. No Ia antigens were detectable on the parental tumor line Eb. Treatment with recombinant interferon-gamma (IFN-gamma) caused enhancement of class I histocompatibility antigen expression on Eb and ESb tumor lines. In ESb cells the expression of Ia and of Ia-associated invariant chain (Ii) was also increased upon IFN-gamma treatment. No induction of either Ia and Ii antigens was observed upon IFN-gamma treatment of the Eb line. These studies demonstrate a substantial difference between the Eb and ESb tumor lines with respect to: (i) constitutive expression of class II major histocompatibility antigens, and (ii) response to IFN-gamma treatment.
AuthorsL Graf, N Koch, V Schirrmacher
JournalMolecular immunology (Mol Immunol) Vol. 22 Issue 12 Pg. 1371-7 (Dec 1985) ISSN: 0161-5890 [Print] England
PMID3938525 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • Histocompatibility Antigens Class II
  • Interferon-gamma
Topics
  • Animals
  • Antigens, Neoplasm (analysis)
  • Cell Line
  • Electrophoresis, Polyacrylamide Gel
  • Histocompatibility Antigens Class II (analysis)
  • Interferon-gamma (pharmacology)
  • Lymphoma (immunology)
  • Major Histocompatibility Complex
  • Mice
  • Mice, Inbred DBA
  • Radioimmunoassay
  • T-Lymphocytes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: